Rigel Pharmaceuticals, Inc.RIGLNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
43.46%
↑ 119% vs avg
Percentile
P100
Near historical high
Streak
3 yr
Consecutive growthExpanding
Average
-233.93%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 43.46% | +173.2% |
| 2024 | 15.90% | +209.5% |
| 2023 | -14.53% | +67.6% |
| 2022 | -44.80% | -492.3% |
| 2021 | -7.56% | +70.3% |
| 2020 | -25.49% | +77.1% |
| 2019 | -111.11% | +29.2% |
| 2018 | -157.02% | +90.9% |
| 2017 | -1728.97% | -459.1% |
| 2016 | -309.23% | - |